Bg pattern

FUCIBET LIPID 20 mg/g + 1 mg/g CREAM

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use FUCIBET LIPID 20 mg/g + 1 mg/g CREAM

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

FucibetLipid20 mg/g + 1 mg/g cream

fusidic acid/betamethasone

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
    • If you experience any side effects, talk to your doctor or pharmacist, even if they are not listed in this leaflet. See section 4.

Contents of the pack

  1. What Fucibet Lipid is and what it is used for
  2. What you need to know before you use Fucibet Lipid
  3. How to use Fucibet Lipid
  4. Possible side effects
  5. Storage of Fucibet Lipid
  6. Contents of the pack and further information

1. What Fucibet Lipid is and what it is used for

Fucibet Lipid cream contains two different types of medicines. One is an antibiotic (fusidic acid) and the other is a potent corticosteroid (betamethasone as valerate). Fusidic acid works by stopping the growth of bacteria and betamethasone works by reducing inflammation and itching of the skin.

Antibiotics are used to treat bacterial infections and do not work for viral infections.

It is important that you follow the instructions regarding dose, administration interval, and treatment duration indicated by your doctor.

Do not store or reuse this medicine. If you have any leftover antibiotic after finishing the treatment, return it to the pharmacy for proper disposal. Do not throw away medicines via wastewater or household waste.

Fucibet Lipid cream is used to treat skin problems caused by bacterial infections sensitive to fusidic acid.

Always use this medicine exactly as your doctor has told you.

You should consult a doctor if you do not improve or if you get worse after treatment.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you use Fucibet Lipid

Do not use Fucibet Lipid:

  • if you are allergic to fusidic acid, betamethasone or any of the other ingredients of this medicine (listed in section 6),
  • in children who wear nappies,
  • in children under one year of age.

Do not use Fucibet Lipid to treat:

  • systemic fungal infections (deep infections caused by a fungus),
  • skin conditions caused by a fungus, virus or bacteria,
  • rosacea (intense redness, especially in the center of the face),
  • eczema around the mouth,
  • tuberculosis (TB),
  • acne.

Warnings and precautions

Consult your doctor or pharmacist before starting to use Fucibet Lipid.

Do not use Fucibet Lipid for longer than necessary, or for longer than your doctor has told you. You should not use Fucibet Lipid for more than two weeks.

Avoid getting Fucibet Lipid in contact with your eyes, open wounds, or mucous membranes (delicate skin lining, for example, in the mouth or nasal passages).

Consult your doctor if you experience blurred vision or other visual disturbances.

Fucibet Lipid may mask possible symptoms of infection.

Fucibet Lipid may potentially increase the risk of infectious diseases, worsen existing infections, or reactivate latent infections.

Children and adolescents

Fucibet Lipid should be used with caution in children and is contraindicated in children under one year of age. A thin layer should be applied. Avoid applying large amounts of medicine and/or covering the skin with dressings or bandages (occlusion). Do not use in children who wear nappies. Use this medicine exactly as your doctor has told you. Avoid prolonged treatment. Children are more prone to possible side effects of corticosteroids.

Other medicines and Fucibet Lipid

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

You can use Fucibet Lipid with other medicines.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.

Pregnancy:you should only use Fucibet Lipid following your doctor's instructions.

Breastfeeding:Fucibet Lipid can be used for a short period during breastfeeding. Consult your doctor. Do not apply Fucibet Lipid to your breasts during breastfeeding.

Driving and using machines

Fucibet Lipid does not affect your ability to drive or use machines.

Fucibet Lipid contains methylparahydroxybenzoate (E218), propylparahydroxybenzoate (E216) (preservatives), cetoconazole alcohol, and potassium sorbate.

The content of methylparahydroxybenzoate (E218) and propylparahydroxybenzoate (E216) may cause allergic reactions (possibly delayed). Cetoconazole alcohol and potassium sorbate may cause local skin reactions (such as contact dermatitis). These reactions can occur at any time after using the medicine. Read section 4 to recognize any signs of these types of symptoms.

3. How to use Fucibet Lipid cream

Follow your doctor's instructions for using this medicine exactly. If you are unsure, consult your doctor or pharmacist again.

Recommended dose

Adults: apply a thin layer 2-3 times a day for a maximum of 2 weeks.

Children: apply a thin layer 2-3 times a day. Do not use under nappies. Use this medicine for the time your doctor has told you, for a maximum of 2 weeks.

Instructions for use

Use Fucibet Lipid only on inflamed skin.

After applying Fucibet Lipid, wash your hands carefully, unless your hands are the area being treated.

If you use more Fucibet Lipid than you should

Contact your doctor or pharmacist if you have used more Fucibet Lipid than described in this leaflet or more than your doctor has prescribed, or if you feel unwell.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount ingested.

If you forget to use Fucibet Lipid

If you forget to apply the cream, you should apply it as soon as you remember and continue applying Fucibet Lipid as usual.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Uncommon side effects (may affect up to 1 in 100 people):

Allergic reactions

Redness or rash

Burning sensation on the skin

Itching

Dryness of the skin

Pain at the application site

Irritation at the application site

Rare side effects (may affect up to 1 in 1,000 people):

Redness of the skin

Urticaria

Rash

Swelling at the application site

Blisters at the application site

Frequency not known (cannot be estimated from the available data):

Blurred vision

Side effects caused by treatment with corticosteroids, such as betamethasone, are:

  • Thinning of the skin
  • Eczema
  • Eczema around the mouth
  • Stretch marks
  • Appearance of small visible veins near the surface of the skin
  • Persistent redness of the skin
  • Redness of the skin
  • Lightening of skin color
  • Excessive hair growth
  • Excessive sweating
  • In case of prolonged use, skin hemorrhages may occur.

Systemic side effects caused by treatment with potent corticosteroids, such as betamethasone, are:

  • The adrenal glands may stop working properly, especially with prolonged use.
  • Complications if used too close to the eyes (e.g., increased eye pressure and glaucoma).

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if they are not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Fucibet Lipid

Do not store above 30°C.

Do not store the tube for more than 3 months after first opening.

Do not use this medicine after the expiry date which is stated on the packaging after EXP. The expiry date is the last day of the month stated.

Keep this medicine out of the sight and reach of children.

Medicines should not be disposed of via wastewater or household waste. Return the packaging and any unused medicine to a pharmacy for proper disposal. If you are unsure, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.

6. Contents of the pack and further information

Composition ofFucibet Lipid cream

  • The active substances are: fusidic acid and betamethasone (as valerate). Each gram of cream contains 20 mg of fusidic acid and 1 mg of betamethasone (as valerate).
  • The other ingredients (excipients) are: macrogol-21 stearate ether, white petrolatum, cetoconazole alcohol, liquid paraffin, hypromellose, citric acid monohydrate, potassium sorbate, purified water, and preservatives: methylparahydroxybenzoate (E-218), propylparahydroxybenzoate (E-216), all-rac-α-tocopherol.

Appearance of theproductand pack contents

Fucibet Lipid is a white cream and is available in tubes of 5 g, 15 g, 30 g, and 60 g.

Not all pack sizes may be marketed.

Marketing authorisation holder and manufacturer

Marketing authorisation holder:

LEO Pharma A/S

Industriparken 55

DK-2750 Ballerup

Denmark

Manufacturer:

LEO Laboratories Ltd.

285 Cashel Road, Crumlin

Dublin 12

Ireland

You can ask for more information about this medicine from the local representative of the marketing authorisation holder:

Laboratorios LEO Pharma, S.A.

Via Laietana 33, 7th floor

08003 Barcelona

Spain

This medicine is authorised in the Member States of the European Economic Area under the following names:

Austria: Fucibet Lipid 20 mg/g + 1mg/g Creme

Bulgaria: Fucibet Lipid 20 mg/g + 1mg/g cream

Denmark: Fusidinsyre/betamethasonvalerat ”Leo”

Spain: Fucibet Lipid 20 mg/g + 1mg/g crema

Italy: FUCIMIXBETA 20 mg/g + 1 mg/g crema

Poland: Fucibet Lipid

Portugal: Fucicort Lipid 20 mg/g + 1 mg/g creme

Czech Republic: FUCICORT LIPID 20 MG/G + 1 MG/G

Date of last revision of this leaflet:March 2025

Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es)

Online doctors for FUCIBET LIPID 20 mg/g + 1 mg/g CREAM

Discuss questions about FUCIBET LIPID 20 mg/g + 1 mg/g CREAM, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for FUCIBET LIPID 20 mg/g + 1 mg/g CREAM?
FUCIBET LIPID 20 mg/g + 1 mg/g CREAM requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in FUCIBET LIPID 20 mg/g + 1 mg/g CREAM?
The active ingredient in FUCIBET LIPID 20 mg/g + 1 mg/g CREAM is betamethasone and antibiotics. This information helps identify medicines with the same composition but different brand names.
Who manufactures FUCIBET LIPID 20 mg/g + 1 mg/g CREAM?
FUCIBET LIPID 20 mg/g + 1 mg/g CREAM is manufactured by Leo Pharma A/S. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of FUCIBET LIPID 20 mg/g + 1 mg/g CREAM online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether FUCIBET LIPID 20 mg/g + 1 mg/g CREAM is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to FUCIBET LIPID 20 mg/g + 1 mg/g CREAM?
Other medicines with the same active substance (betamethasone and antibiotics) include CELESTODERM 1 mg/g + 1 mg/g CREAM, DIPROGENTA 0.5 mg/g + 1 mg/g cream, FUCIBET 20 mg/g + 1 mg/g CREAM. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media